Data / Form D filings / PANACELA LABS, INC.
PANACELA LABS, INC.: Form D filings
PANACELA LABS, INC., a biotechnology company in Buffalo, NY, filed 3 Form D notices with the SEC between 2011 and 2015. The latest, on December 23, 2015, reports $2.9 million sold of a $2.9 million offering to 2 investors.
Find out what PANACELA LABS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 73 HIGH STREET, Buffalo, NY, 14203
- Phone
- (716) 849-6810
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2011
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1526077
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 23, 2015 | New notice | $2,902,600 | $2,902,600 | $0 | 2 | Dec 18, 2015 | sec.gov |
| Oct 7, 2011 | New notice | $37,000,000 | $37,000,000 | $0 | 4 | Oct 4, 2011 | sec.gov |
| Jul 19, 2011 | New notice | Indefinite | $1,000 | Indefinite | 8 | Jul 8, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Neil Lyons C | Executive Officer, Director | |
| Dmitry Lyons Lisenkov | Director | |
| Leysan Shaydullina | Director | |
| Yakov Lyons Kogan | Executive Officer | |
| Andrei Lyons Gudkov | Director | |
| Leah Brownlee | Executive Officer, Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Dec 21, 2015 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PANACELA LABS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.